HEALTH● LOWJun 23 · Jun 23, 2026, 11:00 AM
Pfizer lung cancer therapy fails in late-stage trial versus chemotherapy
Seeking Alpha Tech
Pfizer's late-stage clinical trial for a lung cancer therapy failed when compared against chemotherapy. This outcome represents a setback for the development of new lung cancer treatments by the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoCost of caring for an elderly parent rising faster than inflation, study findsCBS NewsHEALTH1h agoEbola outbreak kills more than 5,000 people in Democratic Republic of CongoSky News WorldHEALTH2h agoACA marketplace premiums rising by 13% in 2027Seeking Alpha TechHEALTH3h agoBaking soda and sugar against cockroaches: how to prepare the mixture and where to place itClarín